Paris: French Pharmacy Startup announced Monday that the British government suddenly stopped the agreement to supply tens of millions of Covid-19 vaccines.
England accused Valneva violated its obligations under the supply agreement, which was rejected by the company “violently”.
There are no comments directly from the English side.
Vaccines, made at Valneva factory in Scotland, are currently in the third trial phase and have not been approved by the regulator.
England initially ordered 60 million vaccine doses and retained the option for more than 90 million.
This then adds 40 million further to the order.
The total value of 190 million doses was 1.4 billion euros ($ 1.7 billion), said Valneva.
If the UK uses all his choices, Valneva’s delivery will continue until 2025.
At the time of the agreement, England launched a red carpet to startup, while the EU was more careful dragging his feet.
Valneva was obviously shocked that the carpet had been pulled out of the bottom of his feet.
In his statement, Valneva, headquartered at the Loire Bank, said it would continue all the fields of research and testing and on schedule.
VLA2001 vaccine, made at the Valneva plant in Scotland, is currently in the third trial phase and has not been approved by the regulator.
England initially ordered 60 million vaccine doses and retained the option for more than 90 million.
This then adds 40 million further to the order.
The total value of 190 million doses was 1.4 billion euros ($ 1.7 billion), said Valneva.
If the UK uses all his choices, Valneva’s delivery will continue until 2025.
At the time of the agreement, England launched a red carpet to startup, while the EU was more careful dragging his feet.
Valneva was obviously shocked that the carpet had been pulled out of the bottom of his feet.
In his statement, Valneva, headquartered at the Loire Bank, said it would continue all the fields of research and testing and on schedule.
England ended the contract with the French startup for vaccines
